ACORDA THERAPEUTICS INC's ticker is and the CUSIP is 00484M956. A total of 3 filers reported holding ACORDA THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $3,000 | 0.0% | 4,700 | -6.0% | 0.00% | – |
Q3 2020 | $3,000 | -98.7% | 5,000 | -98.4% | 0.00% | -100.0% |
Q2 2020 | $227,000 | -20.1% | 309,300 | +1.5% | 0.00% | -50.0% |
Q1 2020 | $284,000 | +14100.0% | 304,600 | +30360.0% | 0.00% | – |
Q4 2019 | $2,000 | -96.7% | 1,000 | -95.2% | 0.00% | – |
Q3 2019 | $60,000 | +2900.0% | 20,900 | +6866.7% | 0.00% | – |
Q2 2019 | $2,000 | -99.4% | 300 | -98.8% | 0.00% | -100.0% |
Q1 2019 | $340,000 | -65.5% | 25,600 | -59.5% | 0.00% | -55.6% |
Q4 2018 | $985,000 | -55.5% | 63,200 | -43.9% | 0.01% | -47.1% |
Q3 2018 | $2,213,000 | -53.4% | 112,600 | -32.0% | 0.02% | -58.5% |
Q2 2018 | $4,750,000 | +294.5% | 165,500 | +225.1% | 0.04% | +241.7% |
Q1 2018 | $1,204,000 | +39.4% | 50,900 | +26.3% | 0.01% | +100.0% |
Q4 2017 | $864,000 | +14.1% | 40,300 | +25.9% | 0.01% | -14.3% |
Q3 2017 | $757,000 | -87.9% | 32,000 | -90.0% | 0.01% | -89.2% |
Q2 2017 | $6,280,000 | -50.8% | 318,800 | -47.6% | 0.06% | -56.4% |
Q1 2017 | $12,768,000 | +304.7% | 608,000 | +262.3% | 0.15% | +380.6% |
Q4 2016 | $3,155,000 | +1424.2% | 167,800 | +1594.9% | 0.03% | +1450.0% |
Q3 2016 | $207,000 | -75.0% | 9,900 | -69.5% | 0.00% | -80.0% |
Q2 2016 | $829,000 | -2.4% | 32,500 | +1.2% | 0.01% | -16.7% |
Q1 2016 | $849,000 | +1112.9% | 32,100 | +1428.6% | 0.01% | +1100.0% |
Q1 2015 | $70,000 | +204.3% | 2,100 | +200.0% | 0.00% | 0.0% |
Q2 2013 | $23,000 | – | 700 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Worth Venture Partners, LLC | 102,500 | $66,000 | 0.03% |
GROUP ONE TRADING, L.P. | 309,300 | $227,000 | 0.00% |
SIMPLEX TRADING, LLC | 623 | $45,000 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |